Exhaustive Extractions

At iuvo, we work hard to stay on the cutting edge of new developments in testing and regulatory changes affecting the medical device and pharmaceutical industries. We will share these updates regularly here in our blog - Exhaustive Extractions.


Oculos Partner Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials

RUSH, NY – September 5, 2019 – Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company and partner of iuvo BioScience’s ophthalmic-focused Oculos Division, announced that it has successfully enrolled 39 glaucoma patients in ORION-1 at 5 U.S. sites from late May to August 2019.  Ocuphire has been collaborating closely with Oculos Development Services to achieve these clinical […]

Podcast: iuvo CEO Ben Burton on the Legal Drugs Podcast

September 3, 2019 – iuvo CEO Ben Burton was interviewed on the Legal Drugs Podcast in the most recent episode (episode 5) which became available September 2. The interview took place at the 2019 Society of Toxicology meeting, and provided an opportunity for Ben to speak with Legal Drugs Podcast host Angela Stoyanovitch on testing […]

iuvo Participates in Rochester Day of Caring Spring Clean Up

May 10, 2019 – Ten iuvo employees volunteered at an Epilepsy Pralid Individualized Residential Alternative (IRA) home yesterday as part of the Rochester Day of Caring event. This was our first year participating in the event and we were able to spruce up the outdoors for spring by mulching, planting, weeding, and doing some general […]

iuvo Chili Cook-off to Support United Way a Gastronomical Success

Wednesday, April 17, 2019 – The air was tense as the inaugural iuvo Chili Cook-off to Support the United Way got under way in the iuvo Canteen at high noon-ish on Wednesday. The contestants had been preparing for, well, at least 24 hours, for this challenge. The discerning judges had inscrutable facades as they tasted each […]

Join us for our Webinar on Biocompatibility and the EU MDR

iuvo will be teaming up with R&Q for a webinar on Biocompatibility: EU MDR and the Changing Regulatory Landscape.  The webinar is March 26, 2019, from 1-2pm ET. The slides, webinar recording, and Q&A will be made available to registrants after the webinar. The session will dive into the increased specificity of the EU MDR from […]

iuvo Workshop at the University of Rochester to Introduce ISO-10993 to Engineering Students

On Friday, March 8, 2019, Dr. Mary Richardson and Dr. Kathleen Krenzer from iuvo’s toxicology department lectured and conducted a workshop on ISO-10993 Biocompatibility testing at the University of Rochester. The workshop was conducted for Biomedical engineering students taking a graduate level course on medical devices.  The primary goal was to help the students understand […]

iuvo Staff Co-authors Paper on Pig-a Gene Mutation by Flow Cytometry

March 4, 2019 – Several members of the iuvo BioScience toxicology team co-authored a paper entitled Suitability of Long-Term Frozen Rat Blood Samples for the Interrogation of Pig-a Gene Mutation by Flow Cytometry. The paper was co-authored by Dr. Mary Richardson, Matt Barragato, Brett Schneider and John Prattico of iuvo, along with Avlasevich, et al, […]

ISO Publishes New Technical Standard: ISO/TS 21726:2019 Biological Evaluation of Medical Devices

The International Standards Organisation (ISO) recently published a new technical standard, ISO/TS 21726:2019 Biological evaluation of medical devices – Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents.  The TTC is a recognized tool for evaluating the biological risks of impurities when they are present at low levels and […]